Glyaderm + Split Thickness Skin Graft Versus Split Thickness Skin Graft Alone in Full Thickness Skin Defects

December 4, 2014 updated by: University Hospital, Ghent

Clinical Application of a Novel Dermal Substitute Based on Glycerol Preserved Allograft: GLYADERM

The application of Glyaderm for skin restoration intends to provide a more stable wound closure with enhanced pliability and function of the skin and a more favourable scar. The dermal substitute would be affordable for widespread application in full thickness skin defects and burns.

Patients with burn wounds or large full thickness wounds will be evaluated before enrollment. All burn wounds that are not clearly full thickness on clinical assessment will be treated during the first 48 hours with a hydrocolloid paste and covered with a paraffin gauze dressing. This hydrocolloid paste combined with paraffin gauze will ensure maintenance of a moist wound environment for the first 48 hours prior to assessment by LDI and randomization. This is the standard treatment for all burns admitted to the Ghent Burn Centre.

Wounds will be photographed on a daily basis. In order to obtain an optimal preparation for LDI, the burn wounds will be meticulously debrided during dressing changes. LDI is most reliable between 48-72 hours. Patients whose burn wounds meet the inclusion criteria, i.e. full thickness burns with LDI values < 200 will be randomized to receive either GLYADERM and split skin graft versus split skin graft alone.

Study Overview

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ghent, Belgium, 9000
        • University Hospital Ghent

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 80 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All burn wounds with flux values measured by Laser Doppler Imaging, corresponding with an expected healing time longer than 28 days. Dark blue color on the palette of the LDI software with flux values below 200
  • All clearly full thickness burns on clinical assessment done by two plastic surgeons and thereafter treated with Flammacerium®.
  • Wounds treated with a hydrocolloid paste prior to LDI and with low flux values < 200
  • All assessments are done during first days before final decision at day three
  • Possibility to follow the complete treatment schedule until final graft take and subsequently wound healing and finally participation on complete follow-up schedule
  • Informed consent has been obtained
  • TBSA Full Thickness Burn < 40%

Exclusion Criteria:

  • All burn wounds with flux values measured by Laser Doppler Imaging, corresponding with faster healing times ( flux values >200 )
  • TBSA >40 %
  • Not following the complete treatment schedule or missing some evaluations during the follow-up period
  • Patient has any condition(s) that seriously compromises the patient's ability to complete this study.
  • Patient has participated in another study utilizing an investigational drug within the previous 30 days
  • Patient has one or more medical condition(s), diabetes, including renal, hepatic, hematologic, neurologic, or immune disease that in the opinion of the investigator would make the patient an inappropriate candidate for this study
  • Patients wish to decline from the study
  • No informed consent before start of the trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Glyaderm and split skin graft
Full thickness defects treated with Glyaderm and split skin graft.
Full thickness defects treated with Glyaderm and split skin graft.
Active Comparator: Split skin graft alone
Full thickness defects treated with split skin graft alone.
Full thickness defects treated with split skin graft alone.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Comparison of healing time and percentage of autograft survival
Time Frame: After one week
After one week
Comparison in bacterial control in full thickness defects
Time Frame: On day 3,5 an 7 post application of Glyaderm
On day 3,5 an 7 post application of Glyaderm
To assess the monitoring of dermal substitute ingrowth with Laser Doppler Imaging
Time Frame: On day 3, 5 and 7 post application of Glyaderm
On day 3, 5 and 7 post application of Glyaderm

Secondary Outcome Measures

Outcome Measure
Time Frame
To evaluate the functional and cosmetic outcome of skin restoration of full thickness defects treated with Glyaderm and split skin graft versus split skin graft alone
Time Frame: 1 month, 3, 6 and 12 months post wound closure
1 month, 3, 6 and 12 months post wound closure
Cost-effectiveness and Health related quality of life (i.e. cost utility analysis)
Time Frame: 1 month, 3, 6 and 12 months post wound closure
1 month, 3, 6 and 12 months post wound closure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2007

Primary Completion (Actual)

February 1, 2012

Study Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

December 15, 2009

First Submitted That Met QC Criteria

December 15, 2009

First Posted (Estimate)

December 16, 2009

Study Record Updates

Last Update Posted (Estimate)

December 5, 2014

Last Update Submitted That Met QC Criteria

December 4, 2014

Last Verified

December 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • 2007/033

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Full Thickness Skin Defects

Clinical Trials on Glyaderm and split skin graft

Subscribe